A case of voluntary intoxication with efavirenz and lamivudine [11]

AIDS

Volumn 20, Issue 9, 2006, Pages 1352-1354

  Boscacci, Rémy T ^a   Buclin, Thierry ^b   Furrer, Hansjakob ^a   Fux, Christoph A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; AGITATION; CASE REPORT; DIARRHEA; DRUG INTOXICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; LETTER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PRURITUS; RASH; SUICIDE ATTEMPT; TABLET; VISUAL HALLUCINATION;

ADOLESCENT; FEMALE; HUMANS; LAMIVUDINE; OXAZINES; REVERSE TRANSCRIPTASE INHIBITORS; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED;

EID: 33745869105     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000232256.97027.c9     Document Type: Letter

References (12)

1. Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. http://AIDSinfo.nih.gov Accessed, 29 October 2004.
2. Blanch J, Corbella B, Garcia F, Parellada E, Gatell JM. Manic syndrome associated with efavirenz overdose. Clin Infect Dis 2001; 33:270-271.
3. Hasse B, Gunthard HF, Bleiber G, Krause M. Efavirenz intoxication due to slow hepatic metabolism. Clin Infect Dis 2005; 40:e22-e23.
4. Barrett JS, Joshi AS, Chai M, Ludden TM, Fiske WD, Pieniaszek HJ Jr. Population pharmacokinetic meta-analysis with efavirenz. Int J Clin Pharmacol Ther 2002; 40:507-519.
5. Adkins JC, Noble S. Efavirenz. Drugs 1998; 56:1055-1064; discussion 1065-1066.
6. Puzantian T. Central nervous system adverse effects with efavirenz: case report and review. Pharmacotherapy 2002; 22:930-933.
7. Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 2001; 15:71-75.
8. Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, et al. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 2005; 143:714-721.
9. Poulsen HD, Lublin HK. Efavirenz-induced psychosis leading to involuntary detention. AIDS 2003; 17:451-453.
10. de la Garza CL, Paoletti-Duarte S, Garcia-Martin C, Gutierrez-Casares JR. Efavirenz-induced psychosis. AIDS 2001; 15:1911-1912.
11. Yoshimoto E, Konishi M, Takahashi K, Murakawa K, Maeda K, Mikasa K, et al. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med 2004; 43:630-631.
12. Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 11:399-415 [Erratum in: Pharmacogenetics 2001; 11:643].